COSM Logo

Cosmos Health Inc. (COSM) 

NASDAQ
Market Cap
$15.34M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
334 of 958
Rank in Industry
15 of 58

Largest Insider Buys in Sector

COSM Stock Price History Chart

COSM Stock Performance

About Cosmos Health Inc.

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It …

Insider Activity of Cosmos Health Inc.

Over the last 12 months, insiders at Cosmos Health Inc. have bought $49,806 and sold $0 worth of Cosmos Health Inc. stock.

On average, over the past 5 years, insiders at Cosmos Health Inc. have bought $3.01M and sold $682,752 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Siokas Grigorios (Chief Executive Officer) — $49,806.

The last purchase of 60,000 shares for transaction amount of $49,806 was made by Siokas Grigorios (Chief Executive Officer) on 2024‑02‑16.

List of Insider Buy and Sell Transactions, Cosmos Health Inc.

2024-02-16PurchaseChief Executive Officer
60,000
0.3544%
$0.83$49,806-10.60%
2023-10-12PurchaseChief Executive Officer
6,712
0.942%
$23.66$158,806-22.48%
2023-07-20PurchaseChief Executive Officer
181,451
2.2312%
$2.48$449,998-44.88%
2023-06-06PurchaseChief Executive Officer
4,474
0.2639%
$23.92$107,018-71.73%
2023-04-27PurchaseChief Executive Officer
4,474
0.2893%
$24.64$110,239-67.13%
2023-04-21PurchaseChief Executive Officer
4,474
0.3236%
$24.49$109,568-62.38%
2023-04-07PurchaseChief Executive Officer
2,238
0.1663%
$24.37$54,540-55.81%
2022-12-19PurchaseChief Executive Officer
260,870
20.4991%
$11.50$3M-59.35%
2022-11-28SaleChief Executive Officer
498
$0.62$310+432.76%
2022-11-28PurchaseChief Executive Officer
801,261
1.7812%
$0.62$497,984+432.76%
2022-10-20PurchaseChief Executive Officer
12.5M
35.4414%
$0.12$1.5M+3411.36%
2022-06-15PurchaseChief Executive Officer
1,500
$0.62$932-1.49%
2021-12-08PurchaseChief Executive Officer
125,000
1.3275%
$6.00$750,000-77.86%
2021-10-22SaleChief Executive Officer
341,900
0.3987%
$0.82$281,559-74.19%
2021-07-20SaleChief Executive Officer
273,450
0.8594%
$2.32$634,773-21.11%
2021-07-20Purchase
100,000
0.0001%
$0.00$100-21.11%
2021-07-19PurchaseChief Executive Officer
208,333
1.6963%
$6.00$1.25M-20.93%
2021-07-13PurchaseChief Executive Officer
166,667
1.448%
$6.00$1M-14.93%
2021-06-23PurchaseChief Executive Officer
500,000
3.7255%
$6.00$3M-29.30%
2021-06-17SaleChief Executive Officer
562,000
0.2494%
$0.42$236,520-39.05%

Insider Historical Profitability

383.15%
Siokas GrigoriosChief Executive Officer
1394597
5.9958%
$0.661936+383.15%
MAVROGIANNIS VASILEIOS10 percent owner
9700227
41.7042%
$0.6628
GOLDSTEIN PETER
157100
0.6754%
$0.6610

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.